Preliminary Study on the Application of Pregnancy-Sociated Plasma Protein-A, Disintegrin-Metalloproteinase 12 in Prenatal Screening During First Trimester

doi:10.3877/cma.j.issn.1673-5250.2014.04.015

Objective

To discuss the application of pregnancy-sociated plasma protein (PAPP)-A, disintegrin-metalloproteinase (ADAM) 12 in prenatal screening during first trimester.

Methods

A total of 1 609 samples which were collected from pregnant women receiving prenatal screening in the first trimester in Gansu Provincial Maternity and Child-Care Hospital from May 2010 to July 2012 were included into this study. Their age ranged from 18 to 45 years old, and gestational age ranged from 9 to 13⁺⁶ gestational weeks. Auto-DELFLA were used to test the levels of serum ADAM 12, PAPP-A and free β-human chorionic gonadotrophin(hCG), then the results were analyzed by LifeCycle 3.0 risk assessment software. Furthermore, the relationship between fetal risks [Down syndrome (DS), open neural tube defect (ONTD), trisomy 18 syndrome] and levels of ADAM12, PAPP-A, free β-hCG were detected. The study protocol was approved by the Ethical Review Board of Investigation in Human Being of Gansu Provincial Maternity and Child-Care Hospital. Informed consent was obtained from each participants' parents.

Results

Among the 1 609 samples, the levels of free β-hCG, PAPP-A and ADAM12 increased with gestational age. The related indexes of serum free β-hCG, PAPP-A and ADAM12 showed positive correlations with gestational weeks (r = 0.955 2, 0.993 3, 0.996 5 ; P<0.05). The results of linear regression analysis among serum free β-hCG, PAPP-A and ADAM12 showed strong positive correlation (free β-hCG vs. PAPP-A, r=0.949 0,P<0.05;free β-hCG vs. ADAM12, r=0.944 0, P<0.05; ADAM12 vs. PAPP-A, r = 0.977 0, P<0.05). In addition, of the 1 609 samples, eleven cases (0.68%) had chromosome abnormalities, including four cases of 45, XO (0.25%), three cases of DS (0.19%), two cases of neural tube defects (0.12%), one case of 18-trisomy syndrome (0.06%), one case of 13-trisomy syndrome (0.06%). The multiples of median (MoM) levels of serum PAPP-A and ADAM12 were lower than those of normal chromosome pregnant women.

Conclusions

Serum PAPP-A and ADAM12 could be used as indicators of prenatal screening for chromosomal abnormalities during the first trimester.

Key words: Serum disintegrin-metalloproteinase 12, First trimester, Prenatal diagnosis

表1 各孕周孕妇的一般资料比较(±s)

Table 1 Comparison of general clinical data among pregnant women with different gestational weeks (±s)

孕龄(周）	n	年龄(岁）	体质量(kg)
9～10	80	30.12±3.93	56.53±9.39
>10～11	198	29.23±4.09	56.68±8.12
>11～12	323	28.79±3.83	57.62±9.20
>12～13	521	28.95±3.36	55.26±7.18
>13～13⁺⁶	487	39.28±3.64	57.43±8.00
t		1.32	1.21
P		>0.01	>0.01

表1 各孕周孕妇的一般资料比较(±s)

Table 1 Comparison of general clinical data among pregnant women with different gestational weeks (±s)

孕龄(周）	n	年龄(岁）	体质量(kg)
9～10	80	30.12±3.93	56.53±9.39
>10～11	198	29.23±4.09	56.68±8.12
>11～12	323	28.79±3.83	57.62±9.20
>12～13	521	28.95±3.36	55.26±7.18
>13～13⁺⁶	487	39.28±3.64	57.43±8.00
t		1.32	1.21
P		>0.01	>0.01

表2 不同孕周孕妇血清PAPP-A、游离β-hCG和ADAM12水平比较(MoM)

Table 2 Comparison of Serum PAPP-A, free β-hCG, ADAM12 levels in pregnant women with different gestational weeks

孕龄(周）	n	游离β-hCG(ng/mL)	PAPP-A( mIU/mL)	ADAM12(ng/mL)
9～10	80	34.40	995	303.12
>10～11	198	40.30	1 560	355.20
>11～12	323	44.35	2 980	451.39
>12～13	521	47.40	3 790	512.80
>13～13⁺⁶	487	47.85	4 710	598.12

表2 不同孕周孕妇血清PAPP-A、游离β-hCG和ADAM12水平比较(MoM)

Table 2 Comparison of Serum PAPP-A, free β-hCG, ADAM12 levels in pregnant women with different gestational weeks

孕龄(周）	n	游离β-hCG(ng/mL)	PAPP-A( mIU/mL)	ADAM12(ng/mL)
9～10	80	34.40	995	303.12
>10～11	198	40.30	1 560	355.20
>11～12	323	44.35	2 980	451.39
>12～13	521	47.40	3 790	512.80
>13～13⁺⁶	487	47.85	4 710	598.12

表3 羊水穿刺染色体核型分析结果异常孕妇血清PAPP-A、游离β-hCG及ADAM12水平(MoM)

Table 3 Comparison of serum PAPP-A,free β-hCG and ADAM12 levels among three cases with DS and one case with 18-trisomy syndrome (MoM)

患者(No.)	染色体结果	年龄(岁）	孕龄(周）	ADAM12	PAPP-A	游离β-hCG
1	47，XX，+21	30	13⁺³	1.485	1.017	1.485
2	47，XX,+21	36	11⁺⁶	0.374	0.190	0.374
3	47，XY，+21	32	11⁺¹	0.227	0.400	1.631
4	47，XY,+ 18	35	13⁺⁴	1.196	0.240	2.196

表3 羊水穿刺染色体核型分析结果异常孕妇血清PAPP-A、游离β-hCG及ADAM12水平(MoM)

Table 3 Comparison of serum PAPP-A,free β-hCG and ADAM12 levels among three cases with DS and one case with 18-trisomy syndrome (MoM)

患者(No.)	染色体结果	年龄(岁）	孕龄(周）	ADAM12	PAPP-A	游离β-hCG
1	47，XX，+21	30	13⁺³	1.485	1.017	1.485
2	47，XX,+21	36	11⁺⁶	0.374	0.190	0.374
3	47，XY，+21	32	11⁺¹	0.227	0.400	1.631
4	47，XY,+ 18	35	13⁺⁴	1.196	0.240	2.196

1	崔洪艳．妊娠11~13⁺⁶周胎儿染色体非整倍体异常产前筛查与诊断策略[D]．天津医科大学，2013.
2	戚红．解整合素-金属蛋白酶12作为产前筛查标志物的初步研究[D]．北京协和医院，2008.
3	王民．解整合素金属蛋白酶12在产前诊断唐氏综合征中应用的研究[D]．浙江大学，2011.
4	ACOG Praetice Bulletin No. 77: screening for fetal chromosomal abnormalities[J]. Obstet Gynecol, 2007, 109(1):217-227.
5	Kagan KO, Wright D, Baker A, et al. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A[J]. Ultrasound Obstet Gynecol, 2008, 31(6):618-624.
6	Leung TY, Spencer K, Leung TN, et al. Higher median levels of free beta-hCG and PAPP-A in the first trimester of pregnancy in a Chinese ethnic group. Implication for first trimester combined screening for Down' s syndrome in the Chinese population [J]. Fetal Diagn Ther, 2006, 21(1):140-143.
7	李治国．孕酮及PAPP-A在先兆流产预测中的应用[J]．中国优生与遗传杂志，2006，14(11)：72.
8	Brambati B, Macintosh MC, Teisner B, et al. Low maternal serum levels of pregnancy associated plasma protein A (PAPP-A) in the first trimester in association with abnormal fetal karyotype [J]. Br J Obstet Gynaecol, 1993, 100(4):324-326.
9	程霞．NT联合free-β-hCG及PAPP-A在妊娠早期唐氏综合征诊断中的临床研究[J]．中国实验诊断学，2013，17(9)：1663-1665.
10	林琳华，方群，游泽山，等．PAPP-A在妊娠晚期对非整倍体胎儿的筛査[J]．中山大学学报，2004，25(3)：272-275.
11	张颖．解整合素-金属蛋白酶12在染色体非整倍体筛查中的应用[J]．国际生殖健康/计划生育杂志，2012，31(4)：257-259.
12	张晓娟，蒋涛，孙云，等．解整合素金属蛋白酶12分泌型在筛查孕中期18-三体综合征胎儿中的应用[J]．临床检验杂志，2012，30(5)：331-333.
13	Laigaard J, SØrensen T, Fröhlich C, et al. ADAM12: a novel first-trimester maternal serum marker for Down syndrome [J]. Prenat Diagn, 2003, 23(13):1086-1091.
14	Christiansen M, Pihl K, Hedley PL, et al. ADAM12 may be used to reduce the false positive rate of first trimester combined screening for Down syndrome[J]. Prenat Diagn, 2010, 30(2):110-114.
15	Spencer K, Cowans NJ. ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy [J]. J Matern Fetal Neonatal Med, 2007, 20(9):645-650.
16	Becherer JD, Blobel CP. Biochemical properties and functions of membrane-anchored metalloprotease-disintegrin proteins (ADAMs)[J]. Curr Top Dev Biol, 2003, 54:101-123.

[1]	Lili Gu, Fan Jiang. Survey and analysis of quality of screening prenatal ultrasound images in Anhui Province[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(07): 671-674.
[2]	Yan Xu, Tong Ru, Mingming Zheng, Yan Gu, Xiangyu Zhu, Chenchen Yan, Ling Chen, Chenyan Dai. Prenatal ultrasound and MRI characteristics and genetic analysis of Miller-Dieker syndrome[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(03): 281-287.
[3]	Dehui Wang, Xuedong Deng. Evaluation and prognostic analysis of fetal pulmonary atresia with intact interventricular septum by echocardiography[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(12): 1266-1270.
[4]	Tao Zhang, Sheng Zhao, Xiaohong Yang, Yanjuan Bao, Xiuqin Ji, Yanduo Gao, Xiaoyan Zhang. Ultrasound diagnosis of fetal abdominal wall defects in the first trimester[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(11): 1139-1144.
[5]	Shuihua Yang, Guidan He, Guican Qin, Mengfeng Liang, Yanhe Luo, Xueqin Li, Juansong Tang. Echocardioimagedata characteristics of fetal isolated total anomalous pulmonary venous connection and application of high definition flow imaging and spatio-temporal image correlation[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(10): 1061-1067.
[6]	Meifang Zhang, Ying Tan, Qiaozhen Zhu, Xin Wen, Ying Yuan, Yue Qin, Hongbo Guo, Lingxiu Hou, Wenlan Huang, Guiyan Peng, Shengli Li. Artificial intelligence-based quality control of mid-sagittal plane ultrasound images for first trimester fetal crown-rump length[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(09): 945-950.
[7]	Lei Liu, Xin Yang, Xiaohua Xu, Shengmou Lin, Chuqin Xiong, Lilu Nong, Zhenyu Dong, Shengli Li. Measurement of fetal prenasal thickness and nasal bone length as a screening tool for trisomy 21, 18, and 13 in the second trimester of pregancy[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(05): 506-510.
[8]	Jingyu Qian, Mingming Zheng. Interpretation of the Italian guidelines on non-invasive and invasive prenatal diagnosis：executive summary of recommendations for practice the Italian Society for Obstetrics and Gynecology（SIGO）[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 486-492.
[9]	Juan Tan, Jianxin Tan, Binbin Shao, Yan Wang, Zhengfeng Xu. Current research status on non-invasive prenatal testing for fetal with single gene inheritance diseases[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(03): 245-250.
[10]	Chao Xue, Ye Zhang, Ying Zhao, Jiancheng Han, Xiaoyan Gu, Lin Sun, Xiaowei Liu, Wei Song, Yihua He. Ultrasonographic characteristics and prognosis of fetal congenital absent pulmonary valve syndrome[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(04): 410-418.
[11]	Wen Zhang, Yanchun Zhang, Kaibo Liu, Hongyan Xu. Prenatal MRI diagnosis and perinatal outcome of fetal congenital hydrocephalus in Beijing[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(03): 345-349.
[12]	Zhaomin Zeng, Haiyan Yu. Clinical cognition of superfemale syndrome[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(02): 145-150.
[13]	Qing Hu, Haiyan Yu. Fetal intrauterine therapy and evaluation of the risk[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(01): 23-30.
[14]	Yan Chen, Zonghui Feng, Shumin Jiang, Min Li, Fengmei Yi, Ying Tan. Analysis of TSC2 gene variation in a tuberous sclerosis complex family and prenatal diagnosis[J]. Chinese Journal of Diagnostics(Electronic Edition), 2024, 12(02): 112-115.
[15]	Zedong Luan, Nan Yang, Hongmin Qi, Wenyan Pang, Xiaoyan Wang, Yanli Zou, Yaqin Liu, Haoling Wang, Jinting Zhang. Clinical value of echocardiography using five views in diagnosing fetal severe congenital heart malformations in first trimester[J]. Chinese Journal of Diagnostics(Electronic Edition), 2023, 11(03): 190-197.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export